Pharmacological aspects of oxprenolol
Brunner, H.; Hedwall, P.R.; Maier, R.; Meier, M.
Postgraduate Medical Journal 1970(Suppl): 5-14
1970
ISSN/ISBN: 0032-5473 PMID: 4395460 Document Number: 27486
Document emailed within 1 workday
Related Documents
Petrack, B.; Czernik, A.J. 1976: Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol Molecular Pharmacology 12(2): 203-207Prichard, B.N. 1990: Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists Zeitschrift für Kardiologie 79(Suppl 3): 99-103
Cowan, A. 2003: Buprenorphine: new pharmacological aspects International Journal of Clinical Practice. Suppl 52(133): 3-8; Discussion: 23-24
Uteshev, D.B.; Sergeev, A.V.; Uteshev, B.S. 1998: Apoptosis: the pharmacological aspects Eksperimental'naia i Klinicheskaia Farmakologiia 61(4): 57-65
Luĭk, A.I.; Lipkan, G.N. 1988: Pharmacological aspects of the problem of leukotrienes Farmakologiia i Toksikologiia 51(4): 104-109
Persson, C.G. 1980: Some pharmacological aspects of xanthines in asthma European Journal of Respiratory Diseases. Suppl 109: 7-16
Singla, A.K.; Chawla, M.; Singh, A. 2000: Nimesulide: some pharmaceutical and pharmacological aspects--an update Journal of Pharmacy and Pharmacology 52(5): 467-486
Dresse, A. 1981: Pharmacological aspects of chronic cerebral insufficiency Revue Medicale de Liege 36(12): 522-523
Kovalenko, A.N. 1986: Clinical and pharmacological aspects of atherosclerosis in middle and old age Fel'dsher i Akusherka 51(11): 32-37
Negrete, J.C. 1976: Pharmacological and psychosocial aspects of drug dependence Acta Psiquiatrica y Psicologica de America Latina 22(4): 306-312
Haas, S.; Blümel, G. 1978: Pharmacological aspects of the effect of dihydergot on the intestines Die Medizinische Welt 29(50): 1982-1984
Ikeda, Y. 1992: Pharmacological aspects of a novel antiplatelet drug, E5510 Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 366-371
Scuvée-Moreau, J.; Dresse, A. 1982: Monoamines and endogenous depression. Biochemical and pharmacological aspects Revue Medicale de Liege 37(1): 1-7
Sedvall, G. 1972: Clinico-pharmacological aspects of prescription of sedatives and hypnotics Lakartidningen 69(12): 1373-1377
Walsmann, P.; Markwardt, F. 1981: Biochemical and pharmacological aspects of the thrombin inhibitor hirudin Die Pharmazie 36(10): 653-660
Leboyer, M. 1986: Endorphins. Physiological and pharmacological aspects, and research in psychiatry L'Encephale 12(2): 45-62
Anderson, G.M.; Shaywitz, B.A.; Leckman, J.F.; Hunt, R.D.; Shaywitz, S.E.; Cohen, D.J. 1983: Developmental and pharmacological aspects of attention deficit disorder (ADD) Progress in Clinical and Biological Research 135: 207-223
Saito, I.; Suzuki, A.; Saiko, Y.; Yokozawa, M.; Ono, K.; Miyata, K.; Miyamura, R.; Hamaya, O.; Kaneko, K.; Yamamoto, T. 1992: Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin Hinyokika Kiyo. Acta Urologica Japonica 38(5): 623-628
Kulkarni, S.K.; Patil, C.S. 2004: Phosphodiesterase 5 enzyme and its inhibitors: update on pharmacological and therapeutical aspects Methods and Findings in Experimental and Clinical Pharmacology 26(10): 789-799
Díez, J.J.; Gómez-Pan, A. 1993: New physiological and pharmacological aspects of the growth hormone (I). the effects in adults Revista Clinica Espanola 192(6): 280-287